M&A activity among US medical device and diagnostic healthcare companies could accelerate in 2021 after a relatively subdued 2020 as the operating environment stabilizes and companies position themselves for future growth, says Fitch Ratings. Additionally, a number of medical technology special purpose acquisition companies (SPACs), which typically have 18-24 months to complete an initial business combination, went public in 2020. This could set the stage for an uptick in transactions and potentially drive up valuations.
Read the full article: US Medical Device, Diagnostics Healthcare M&A Poised to Increase //
Source: https://www.fitchratings.com/research/corporate-finance/us-medical-device-diagnostics-healthcare-m-a-poised-to-increase-25-01-2021